Atlas Trials

Deferoxamine and Xingnaojing Injection Treatment in Intracerebral Hemorrhage

Clinical trial NCT02367248 · UNKNOWN

Trial details

NCT number
NCT02367248
Sponsor
Capital Medical University
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Intracerebral Hemorrhage
Start date
2015-03-01
Primary completion
2016-12-01
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.